|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-10-10
|
|
pubmed:abstractText |
To determine the efficacy of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinase, in the treatment of experimental proliferative vitreoretinopathy (PVR) induced by intravitreal dispase injection.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0271-3683
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
447-53
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:10980656-Animals,
pubmed-meshheading:10980656-Antineoplastic Agents,
pubmed-meshheading:10980656-Drug Evaluation, Preclinical,
pubmed-meshheading:10980656-Enzyme Inhibitors,
pubmed-meshheading:10980656-Epiretinal Membrane,
pubmed-meshheading:10980656-Female,
pubmed-meshheading:10980656-Fundus Oculi,
pubmed-meshheading:10980656-Male,
pubmed-meshheading:10980656-Matrix Metalloproteinases,
pubmed-meshheading:10980656-Organic Chemicals,
pubmed-meshheading:10980656-Rabbits,
pubmed-meshheading:10980656-Retina,
pubmed-meshheading:10980656-Vitreoretinopathy, Proliferative
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy.
|
|
pubmed:affiliation |
Shiley Eye Center, University of California, San Diego, California 92093-0946, United States of America.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
